Population pharmacokinetics of rotigotine extended‐release microspheres for intramuscular injection in patients with early‐stage Parkinson's disease

Documents similaires

• A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres
  par: Xinyu Zhao, et autres
  Publié: (2024)
• Population pharmacokinetics of long‐term hydroxychloroquine therapy in patients with rheumatic diseases
  par: Chunlan Yang, et autres
  Publié: (2024)
• Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease
  par: Muhammad Waqas Sadiq, et autres
  Publié: (2024)
• Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity
  par: Naïm Bouazza, et autres
  Publié: (2025)
• Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin‐resistant tuberculosis
  par: Sharon Sawe, et autres
  Publié: (2025)